Q-Line Biotech (NSE:QLINE) Construction In Progress: ₹602 Mil (As of Mar. 2025)


NSE:QLINE Q-Line Biotech Ltd NSE:QLINE
12 GF Score
Price ₹546.50
! 2 Warning Signs
View Full Analysis

What is Q-Line Biotech Construction In Progress?

Q-Line Biotech NSE:QLINE -5.15% 12 Construction In Progress is ₹602 Mil as of Mar. 2025. GuruFocus rates NSE:QLINE with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Q-Line Biotech's quarterly construction in progress increased from Mar. 2023 (₹208 Mil) to Mar. 2024 (₹271 Mil) and increased from Mar. 2024 (₹271 Mil) to Mar. 2025 (₹602 Mil).

Q-Line Biotech's annual construction in progress increased from Mar. 2023 (₹208 Mil) to Mar. 2024 (₹271 Mil) and increased from Mar. 2024 (₹271 Mil) to Mar. 2025 (₹602 Mil).

Q-Line Biotech Construction In Progress Historical Data

* Premium members only.

The historical data trend for Q-Line Biotech's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-Line Biotech Construction In Progress Chart

Q-Line Biotech Annual Data
Trend Mar23 Mar24 Mar25
Construction In Progress
207.83 270.69 602.03

Q-Line Biotech Semi-Annual Data
Mar23 Mar24 Mar25
Construction In Progress 207.83 270.69 602.03
NSE:QLINE
12GF Score
Q-Line Biotech Ltd NSE:QLINE
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-Line Biotech Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹602 Mil mean?
Q-Line Biotech (NSE:QLINE) has a Construction In Progress of ₹602 Mil as of Mar. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Q-Line Biotech and its competitors.
Is Q-Line Biotech's Construction In Progress too high?
Q-Line Biotech's current Construction In Progress is ₹602 Mil. Overall, Q-Line Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Q-Line Biotech's Construction In Progress compare to ABT and SYK?
Q-Line Biotech's Construction In Progress of ₹602 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Medical Devices & Instruments company?
A good Construction In Progress depends on the Medical Devices & Instruments industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Q-Line Biotech and its competitors. Q-Line Biotech's current Construction In Progress is ₹602 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-Line Biotech stock overvalued right now?
Q-Line Biotech (NSE:QLINE) has a current Construction In Progress of ₹602 Mil. The current Construction In Progress is ₹602 Mil. Q-Line Biotech's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Q-Line Biotech (NSE:QLINE), the current Construction In Progress is ₹602 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Q-Line Biotech Business Description

Address Kanpur Road Adjacent Transport Nagar Metro Station, 298-281, Transport Nagar, Lucknow, UP, IND, 226012
Q-Line Biotech Ltd is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs directly or through its distributors majorly to diagnostic service providers, hospitals and medical colleges. It is engaged in Manufacturing and Trading into Biochemistry Regnant, Instruments and Consumables. The majority of revenue is derived from the Manufacturing segment.
12GF Score

Get the complete analysis for NSE:QLINE

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹546.50
Price